Independent role of myo-inositol in weight reduction in a polycystic ovarian syndrome patient: A case report
Polycystic ovarian syndrome (PCOS) is a common endocrine-metabolic disorder characterised by insulin resistance, obesity, and menstrual irregularities. Myo-inositol and metformin are frequently used for metabolic correction; however, the independent effect of myo-inositol on anthropometric outcomes remains unclear. This case report describes a 27-year-old female with PCOS who underwent sequential treatment with inositol-based regimens and metformin monotherapy. Weight reduction and improvement in body mass index were observed only during treatment phases containing inositol, whereas no anthropometric change occurred during metformin monotherapy despite equal duration. These findings suggest a potential independent contribution of myo-inositol to weight reduction. Although limited by single-patient observation, this case highlights the need for further controlled studies exploring mechanistic and clinical effects of inositol in PCOS management.
Authors
- Anita Basavaraj
- Ganesh Satyadeo Pentewar
- Sagarika Basavaraj
- Sanjana Basavaraj
Institutions
- B. J. Medical College & Sassoon Hospital (IN)
- Dr. D. Y. Patil Medical College, Hospital and Research Centre (IN)
- Maharashtra Institute of Medical Education and Research (IN)
Publication Details
- Journal
- Indian Journal of Physiology and Pharmacology
- Published
- 2026-11-16
- DOI
- https://doi.org/10.25259/ijpp_416_2025
- Primary Topic
- Ovarian function and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00